Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Jim Van Meerten

Profits May Be Just Around the Corner for This Strong-Buy Pharma Stock

  • Alnylam Pharmaceuticals (ALNY) shows strong price momentum, hitting new all-time highs on Aug. 11.
  • ALNY has a 100% technical “Buy” opinion via Barchart.
  • The company boasts a robust pipeline, recent FDA approvals, and dramatic projected revenue and earnings growth for 2025.
  • Analyst sentiment is mostly bullish with high price targets.

Today’s Featured Stock

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.